Jubilant Ingrevia Competitors and Similar CompaniesClear all

Jubilant Ingrevia's competitors and similar companies include Boehringer Ingelheim Pharma, Clinigen, Perfect Blend Organics and IADFAC Laboratories.

	Jubilant Ingrevia Jubilant Ingrevia is a company that researches and manufactures life science ingredients.	Boehringer Ingelheim Pharma Boehringer Ingelheim Pharma is a research-based pharmaceutical company.	Clinigen Clinigen is a specialist pharmaceutical services company.	Perfect Blend Organics Perfect Blend Organics conducts research and development of biotic fertilizers.	IADFAC Laboratories IADFAC Laboratories is a food testing facility.
Founding Date	Founding Date 2007	Founding Date 1969	Founding Date 2010	Founding Date 2001	Founding Date 2000
Type	Type Public	Type Subsidiary	Type Private	Type Private	Type Private
Tags	Tags Manufacturing & Industrial chemicals clinical research drug development nutrition	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Manufacturing & Industrial chemicals clinical research nutrition	Tags Healthcare chemicals clinical research drug development nutrition
Locations	Locations Noida, IN HQ Uttar Pradesh, IN	Locations Ingelheim am Rhein, DE HQ	Locations Burton upon Trent, GB HQ Warriewood, AU Lyon, FR Koropi, GR Lismore, IE Chuo City, JP Singapore, SG see more	Locations Bellevue, US HQ	Locations Bengaluru, IN HQ
Employees	Employees 2,283	Employees 10,000	Employees 586	Employees N/A	Employees 156% decrease
Financial
Revenue (est.)	Revenue (est.) ₹43.4b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) £562.2m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ₹22.9b (FY, 2026)	Cost of goods N/A	Cost of goods £301.2m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₹21.3b (FY, 2026)	Gross profit N/A	Gross profit £261m (FY, 2021)	Gross profit N/A	Gross profit N/A
Net income	Net income ₹2.8b (FY, 2026)	Net income N/A	Net income £38.7m (FY, 2021)	Net income N/A	Net income N/A